Analyst Recommendations

Barclays analyst issues UNDERWEIGHT recommendation for AAPL on October 29, 2024 08:36AM ET. The previous analyst recommendation was Underweight.AAPL was trading at $233.4 at issue of the analyst...

October 29, 2024   AAPL 0.55%

Barclays analyst issues EQUAL-WEIGHT recommendation for TSLA on October 29, 2024 05:04AM ET. The previous analyst recommendation was Equal-Weight.TSLA was trading at $262.51 at issue of the analyst...

October 29, 2024   TSLA 3.21%

Wolfe Research analyst issues OUTPERFORM recommendation for AMZN on October 28, 2024 07:17AM ET. The previous analyst recommendation was Outperform.AMZN was trading at $189.3098 at issue of the...

October 28, 2024   AMZN 1.01%

Wolfe Research analyst issues CAUTIOUS recommendation for TSLA on October 28, 2024 07:19AM ET. The previous analyst recommendation was Cautious.TSLA was trading at $269.1072 at issue of the...

October 28, 2024   TSLA 3.21%

Guggenheim analyst issues BUY recommendation for WMT on October 28, 2024 09:18AM ET. The previous analyst recommendation was Buy.WMT was trading at $82.92 at issue of the analyst...

October 28, 2024   WMT -0.04%

UBS analyst issues BUY recommendation for AMZN on October 28, 2024 09:41AM ET. The previous analyst recommendation was Buy.AMZN was trading at $189.215 at issue of the analyst...

October 28, 2024   AMZN 1.01%

Morgan Stanley analyst issues OVERWEIGHT recommendation for FMX on October 28, 2024 10:54AM ET. The previous analyst recommendation was Overweight.FMX was trading at $98.18 at issue of the...

October 28, 2024   FMX -0.91%

Cowen & Co. analyst issues BUY recommendation for MSFT on October 24, 2024 08:46AM ET. The previous analyst recommendation was Buy.MSFT was trading at $423.98 at issue of...

October 24, 2024   MSFT -0.32%

Guggenheim analyst issues SELL recommendation for TSLA on October 24, 2024 07:35AM ET. The previous analyst recommendation was Sell.TSLA was trading at $213.65 at issue of the analyst...

October 24, 2024   TSLA 3.21%

Oppenheimer analyst issues OUTPERFORM recommendation for CRM on October 24, 2024 06:37AM ET. The previous analyst recommendation was Outperform.CRM was trading at $284.43 at issue of the analyst...

October 24, 2024   CRM 0.96%